Fintech

LSX World Congress USA

LSX USA Congress gathers leaders from the US biotech, medtech, and pharmatech sectors to network, showcase innovations, and explore partnership opportunities.

Official websiteAgenda
7 weeks until it opens.

The essentials

Event details

Dates
22 September 2026 to 24 September 2026
Location
Hynes Convention Center, Boston, United States
Organiser
Informa Group PLC
Expected attendance
1,000
Industry
Fintech

Public discussion

What people are saying

Agenda themes

Topics covered

  • Early Innovation & Technology Translation

On stage

Speakers

  • Rachel Strick, AbbVie
  • David Lee, Servier Pharmaceuticals
  • Curt LaBelle, AXA IM Global Health Investment Fund BNP Paribas Asset Management
  • Jessica Federer, Board Member, Angelini Ventures
  • Kiran Reddy, Senior Managing Director, Blackstone Life Sciences
  • Jennifer Schranz, SVP Global Head of Rare Diseases, Ipsen
  • Tomoko Hanadate, Astellas Pharma Inc
  • Brian Goodman, Managing Director, Vida Ventures
  • Debra Yu, Panacea Capital
  • Bernard Cooney, Partner, Casdin Capital
  • Christopher Tan
  • Elena Diez Cecilia, Senior Director External Innovation DPDS
  • Mike Patten, Chief Strategy Officer, Harbour BioMed
  • Fei Shen, Boehringer Ingelheim
  • Mary Schaheen, President, Prevail Partners
  • Scott Miller, Executive Director, Alliance and Innovation Management, Eli Lilly
  • Renee Aguiar-Lucander, Chief Executive Officer, Hansa Biopharma
  • Scott DeWire, Boehringer Ingelheim
  • Mankit Law, GSK
  • Carla Bauer, Merck

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.